INTRODUCING

OVItm

The smarter way to take eyedrops.

Learn more

It’s time to make eye drops smarter

An eye drop being dispensed from a bottle.

Droppers are difficult to use

40% of patients report at least one issue with taking an eye drop¹ including hitting the eye, squeezing the bottle and too many drops

An eye drop hitting an eye.

Drop size is too big

The average drop size is 4x larger than the eye can absorb, wasting medication and leading to toxic effects²

A calendar with two days checked, and one day with a question mark.

Drops are hard to remember

There is no pillbox for eye drops. Tracking and managing medication usage can be nearly impossible, and non-adherence is high³

An elderly man with white hair and beard using the OVI smart eye dropper.

Our Platform

A connected device that is compatible with most eye drop bottles to help with alignment and comfort, while delivering high value data insights.

Learn more

We create value across the eye care ecosystem

Illustration of three blue dollar bills, one lying flat and two partially frayed behind it.

For Payers

Avoid costly surgery and additional drops brought on by medication non-adherence.

Blue outline of a medical cross on a black background

For Providers

Use better data for treatment decisions and improve patient experience.

Blue and black capsule pill.

For Pharma

Leverage real-world data for better drug discovery and insights into current portfolio usage.

Outline of a heart above an open hand, all in blue.

For Caretakers

Gain peace of mind that loved ones are taking the right medication, at the right time to preserve vision.

About

Sub22 Technologies is a digital health company on a mission to empower patients who struggle with eye care treatments. We are currently developing the world’s most advanced eye drop aid to help preserve vision.

Learn More

References

[1] Mehuyas et al., (2019). Eye drop technique and patient-reported problems in a real-world population of eye drop users. Nature

[2] Kumar et al., (2011). Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment. Journal of Advanced Pharmaceutical Technology & Research.

[3] Zaharia et al. (2022). Adherence to Therapy in Glaucoma Treatment—A Review. Journal of Personalized Medicine